Plus: Pfizer’s PARP wins prostate approval, Aldeyra receives CRL, and updates from Amgen, Boston Pharma, WestGene and more

Plus: Zentalis, Editas are latest to tap investors for follow-on cash and updates from AbbVie, Mersana, Nordic Bioscience, Aldeyra, Theradaptive

Expected decisions include BioMarin’s hemophilia A gene therapy, a subQ form of argenx’s of myasthenia gravis drug, and Aldeyra’s retinal cancer candidate

Biotech Sisters leading industry response 

Plus: Flamingo teaming up with Dynacure and updates from Debiopharm, Aldeyra, Checkpoint and more

Plus Merck KGaA opening up to larger M&A, Sanofi, Provention to co-promote diabetes treatment and updates from Annovis, Aldeyra and more

BioVentures for Global Health is providing biopharmas a route to help address global inequities in access to cancer drugs